Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator

The cooperation of adaptive immunity with pharmacologic therapy influences cancer progression. Though non-steroidal anti-inflammatory drugs (NSAIDs) have a long history of cancer prevention, it is unclear whether adaptive immune system affects the action of those drugs. In present study, we revealed...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Tao, Wang, Guoping, Ye, Tinghong, Wang, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725989/
https://www.ncbi.nlm.nih.gov/pubmed/26777116
http://dx.doi.org/10.1038/srep19534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725989/
https://www.ncbi.nlm.nih.gov/pubmed/26777116
http://dx.doi.org/10.1038/srep19534

Ejemplares similares